Xconomy National

Archives

by in

Entry	Author	Date	Location
Rib-X Pharma Files for IPO	Arlene Weintraub	11/28/11	Boston
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News	Erin Kutz	07/08/11	Boston
Rib-X Inks Research Agreement With Sanofi	Erin Kutz	07/06/11	Boston
Biotechies Need to Get Serious About Antibiotics, Where There is Money to Be Made	Luke Timmerman	04/04/11	National
Rib-X Pharmaceuticals Garners $5,500,000 New Round	VentureDeal	01/28/11	Boston
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News	Erin Kutz	01/14/11	Boston
$12.7M Blows in for Wind Power Holdings, Epizyme Forges Alliance with GlaxoSmithKline, & Many More Boston-Area Deals	Rebecca Zacks	01/12/11	Boston
Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics	Luke Timmerman	01/11/11	Boston
Rib-X Pharmaceuticals Receives $20,000,000 New Financing Round	VentureDeal	01/11/11	Boston
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference	Luke Timmerman	09/15/10	Boston
Mercator Therapeutics Embarks on Journey to Develop Targeted Cancer Drugs	Ryan McBride	09/01/10	Boston
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News	Erin Kutz	06/16/10	Boston
Rib-X Adds $5.5M Debt	Luke Timmerman	06/11/10	Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics	Luke Timmerman	06/01/10	Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News	Rebecca Zacks	03/26/10	Boston
Former Targanta CEO Leuchtenberger Lands New Gig at Rib-X, Another Antibiotic Company	Luke Timmerman	03/23/10	Boston
Sirtris Founders Resurface with New Fund, Icahn Continues to Make Biotech Waves, Sentillion Bought by Microsoft, & More Boston-Area Life Sciences News	Erin Kutz	02/19/10	Boston
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy	Luke Timmerman	02/16/10	Boston
Rib-X Founder Gets Nobel Prize	Ryan McBride	10/07/09	Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News	Rebecca Zacks	08/12/09	Boston
Rib-X Antibiotic Passes Clinical Trial, Hopes to Snag Partner	Luke Timmerman	08/05/09	Boston
Exact Teams With Genzyme, Shrugs off Sequenom; Virtual Computer Reels in $15M; Beacon Power Inks National Grid Agreement; & More Boston-Area Deal News	Rebecca Zacks	01/30/09	Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News	Rebecca Zacks	01/28/09	Boston
Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial	Ryan McBride	01/26/09	Boston
Rib-X Reveals “Positive” Antibiotic Data	Ryan McBride	12/08/08	Boston
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News	Rebecca Zacks	10/08/08	Boston
Rib-X Pharma, and Its Lead Antibiotic, Gear Up for Prime Time	Ryan McBride	10/02/08	Boston
Page 1 of 1